Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Change in Accrued Expenses (2023)

Updated

Kazia Therapeutics' Change in Accrued Expenses came in at $9,376 for FY2024 (year ended Dec 31, 2024), compared with -$229,666 in FY2023.

Analysis

Kazia Therapeutics (KZIA) Change in Accrued Expenses (2023) Analysis & Trends

Going back to FY2012, Kazia Therapeutics' Change in Accrued Expenses data covers 5 fiscal years.

  • Per Business Quant, earlier fiscal years put Change in Accrued Expenses at -$229,666 in FY2023 and $58,751 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 2.41 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 983.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 756.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Kazia Therapeutics 10.72 Mn -41.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -224,963.43
API Access

Kazia Therapeutics Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=KZIA&period=max&api_key=YOUR_API_KEY